⌘K

Login Start Free

Home/Insiders/Quan Lucinda Y.

QL

SEC Insider//CIK 0001824711

Quan Lucinda Y.

CIK 00018247111 companySOUTH SAN FRANCISCO, CA

Transactions

12

Companies

1

Filings

6

CIK

0001824711

Recent Transactions

12 trades

Award
Aligos Therapeutics, Inc.$ALGS
Stock Option (Right to Buy)
2023-09-08+48,000→ 48,000 total
Award
Aligos Therapeutics, Inc.$ALGS
Stock Option (Right to Buy)
2023-03-15+78,750→ 78,750 total
Award
Aligos Therapeutics, Inc.$ALGS
Stock Option (Right to Buy)
2022-07-07+52,500→ 52,500 total
Award
Aligos Therapeutics, Inc.$ALGS
Stock Option (Right to Buy)
2022-02-04+105,000→ 105,000 total
Award
Aligos Therapeutics, Inc.$ALGS
Stock Option (Right to Buy)
2022-02-04+26,250→ 26,250 total
Award
Aligos Therapeutics, Inc.$ALGS
Stock Option (Right to Buy)
2020-12-01+200,000→ 200,000 total
Conversion
Aligos Therapeutics, Inc.$ALGS
Common Stock
2020-10-20+726→ 9,258 total
Conversion
Aligos Therapeutics, Inc.$ALGS
Series A Preferred Stock
2020-10-20−6,835→ 0 total
Conversion
Aligos Therapeutics, Inc.$ALGS
Series B-2 Preferred Stock
2020-10-20−726→ 0 total
Conversion
Aligos Therapeutics, Inc.$ALGS
Common Stock
2020-10-20+1,697→ 8,532 total
Conversion
Aligos Therapeutics, Inc.$ALGS
Common Stock
2020-10-20+6,835→ 6,835 total
Conversion
Aligos Therapeutics, Inc.$ALGS
Series B-1 Preferred Stock
2020-10-20−1,697→ 0 total

Companies

1

Aligos Therapeutics, Inc.
See Remarks
$ALGS

Recent Filings

6

Address

C/O ALIGOS THERAPEUTICS, INC. 1 CORPORATE DRIVE, 2ND FLOOR

SOUTH SAN FRANCISCO, CA, 94080

View on SEC.gov